Source link : https://www.newshealth.biz/health-news/adding-hipec-boosts-survival-in-recurrent-ovarian-cancer/
Adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian carcinoma, a phase III randomized trial showed. In over 400 women at first epithelial ovarian cancer recurrence, those who received HIPEC had a median OS of 54.3 months compared with 45.8 months for those who […]
Author : News Health
Publish date : 2024-11-14 21:46:31
Copyright for syndicated content belongs to the linked Source.